State of Michigan Retirement System 13F: Adds $17M to ZTS Stake
Key Points
- The State of Michigan Retirement System increased its position in Zoetis by 242,066 shares, raising its total to 757,095 shares worth about $52.9 million.
- As of October 27, 2026, Zoetis shares traded at $78.23, roughly equal to the closing price on the event date, but significantly below their 52-week high of $147.93.
- Zoetis has a forward P/E ratio of 12.6 and a dividend yield of 2.62%, indicating a steady income for shareholders.
Get Zoetis text alerts
We text you when insiders, Congress, analysts or big funds move on $ZTS.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Zoetis Inc. alert may contain errors. Disclosures
The State of Michigan Retirement System boosted its stake in Zoetis Inc. (ZTS) by 242,066 shares in a filing on October 27, 2026. This brings its total holdings to 757,095 shares, valued at about $52.9 million.
ZTS
Zoetis Inc.
What Changed in State of Michigan Retirement System's Zoetis Position
The retirement system added 242,066 shares, a 47.0% increase from the previous total of 515,029 shares. This change represents a reported value of approximately $16.9 million.
Where Zoetis Fits in State of Michigan Retirement System's Portfolio
Zoetis now accounts for about 0.48% of the State of Michigan Retirement System's total reported 13F value, ranking 31 out of 966 positions.
Zoetis Inc. Stock Down 3.5%
Zoetis shares closed at $78.23 on October 27, 2026, which is about equal to the recent trading price. The stock is currently above its 52-week low of $68.77 but well below its high of $147.93, indicating a significant drop in value over the year.
Recent Earnings
Zoetis reported trailing twelve-month revenue of approximately $9.53 billion and an EPS of $6.08. The next earnings report is scheduled for November 5, 2026.
Dividend
Zoetis pays an annual dividend rate of $2.12, resulting in a dividend yield of 2.62%. The payout ratio is 33.9%, suggesting a sustainable dividend policy.
Insider Buying and Selling at Zoetis Inc.
Several insiders have purchased shares recently, including Director Michael B. McCallister, who bought 3,000 shares at an average price of $77.76 on May 11, 2026, totaling about $233,273. Director Paul M. Bisaro also acquired 2,000 shares at $75.88 on May 13, 2026, valued at around $151,750.
Analysts Set New Price Targets
On October 27, 2026, UBS maintained a Neutral rating on Zoetis with a price target of $85. This follows several prior ratings, including a Hold from Stifel with a target of $80 and a Buy from TD Cowen with a target of $94.
About Zoetis Inc.
Zoetis Inc. is a global leader in animal health, focusing on developing medicines, vaccines, and diagnostic products for various animals, including pets and livestock. The company's growth is closely tied to trends in the animal health market and its commitment to innovation.
Bottom Line
Investors should watch for the upcoming earnings report on November 5, 2026, as well as any further changes in institutional holdings or insider transactions that may impact Zoetis' stock performance.
Related Filing Alerts
Source: State of Michigan Retirement System's 13F filing on $ZTS (Oct 27, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Written by software, not financial advice. How we make alerts